Cancer Drug Design and Discovery

Author:   Stephen Neidle (The Institute of Cancer Research, University of London The School of Pharmacy, University of London, UK The School of Pharmacy, University of London, UK University of London)
Publisher:   Academic Press
ISBN:  

9781299954236


Pages:   673
Publication Date:   01 January 2013
Format:   Electronic book text
Availability:   Available To Order   Availability explained
We have confirmation that this item is in stock with the supplier. It will be ordered in for you and dispatched immediately.

Our Price $494.02 Quantity:  
Add to Cart

Share |

Cancer Drug Design and Discovery


Add your own review!

Overview

Cancer Drug Design and Discovery, Second Edition is an important reference on the underlying principles for the design and subsequent development of new anticancer small molecule agents. New chapters have been added to this edition on areas of particular interest and therapeutic promise, including cancer genomics and personalized medicine, DNA-targeted agents and more. This book includes several sections on the basic and applied science of cancer drug discovery and features those drugs that are now approved for human use and are in the marketplace, as well as those that are still under development. By highlighting some of the general principles involved in taking molecules through basic science to clinical development, this book offers a complete and authoritative reference on the design and discovery of anticancer drugs for translational scientists and clinicians involved in cancer research. Provides a clinical perspective on the development of new molecularly targeted anticancer agents with the latest and most promising chemotherapeutic approachesOffers a broad view of where the field is going, what tools drug discovery is using to produce new agents and how they are evaluated in the laboratory and clinicFeatures 6 new chapters devoted to advances in technology and successful anticancer therapies, such as cancer genomics and personalized medicine, DNA-targeted agents, B-Raf inhibitors and moreEach chapter includes extensive references to the primary and review literature, as well as to relevant web-based sources

Full Product Details

Author:   Stephen Neidle (The Institute of Cancer Research, University of London The School of Pharmacy, University of London, UK The School of Pharmacy, University of London, UK University of London)
Publisher:   Academic Press
Imprint:   Academic Press
ISBN:  

9781299954236


ISBN 10:   1299954235
Pages:   673
Publication Date:   01 January 2013
Audience:   General/trade ,  General
Format:   Electronic book text
Publisher's Status:   Active
Availability:   Available To Order   Availability explained
We have confirmation that this item is in stock with the supplier. It will be ordered in for you and dispatched immediately.

Table of Contents

Reviews

Author Information

Tab Content 6

Author Website:  

Customer Reviews

Recent Reviews

No review item found!

Add your own review!

Countries Available

All regions
Latest Reading Guide

MRG2025CC

 

Shopping Cart
Your cart is empty
Shopping cart
Mailing List